Global Market & Pharmaceutical Formulation
Currently North America has surpassed the entire continent in terms of novel drug delivery market in cancer research with a market share of around 38%. Due to excellent research & development in the field of drug delivery system, exceptional adoption rate of new technologies, helpful reimbursement policy – North America has surpassed all the continents in terms of market share. Europe also hold the 2nd position with a very respective market share of around 29% due to large number of cancer patient, development of clinical research facilities, awareness & the novel therapy to the cancer patient.
But Asia is the fastest growing novel delivery market & it shows a huge elevation in growth curve during recent times due to vast research activities, awareness, new therapy procedure, increased no. of cancer patient in china & japan. Currently in holds the 3rd position in global market with a share of around 20% but in future it is expected to boost the market growth. The total value of global NDDS market in 2016 was $4.31 Billion. The growth is boosted at a rate of 22.9% during recent period according to CGAR report.
Various novel pharmaceutical formulations are including the Nano medicine, transdermal patches, enteric coated tablets & capsule, implantable tablet, injectable intravenous & intramuscular preparation, micro bubbles & micro sponges, various Nano particles, microsphere etc.
- • North America dominates global injectable drug delivery market
- • Incremental & predicted drug device enhancement
- • Types & procedure of drug formulation
- • Vegetative formulation
- • Pharmaceutical equipment & drug release testing
- • Academy & industry perspective
Related Conference of Global Market & Pharmaceutical Formulation
November 19-20, 2026
14th International Conference and Exhibition on Natural Products and Medicinal Plants Research
Dubai, UAE
November 26-27, 2026
5th World Conference on Pharma Industry and Medical Devices
Zurich, Switzerland
December 14-15, 2026
5th International Conference and Expo on Pharmaceutics & Novel Drug Delivery Systems
Amsterdam, Netherlands
December 28-29, 2026
15th International Conference on Clinical Research & Clinical Trials
London, UK
February 15-16, 2027
18th International Conference on Pharmaceutical Education and Practice
Rome, Italy
February 15-16, 2027
9th International Conference on Pharmaceutical Research
&
Innovations in Pharma Industry
Rome, Italy
April 01-02, 2027
13th International Conference on Antimicrobials & Antibiotic Resistance
Madrid, Spain
April 29-30, 2027
26th International Conference on Medicinal and Pharmaceutical Chemistry
Geneva, Switzerland
April 29-30, 2027
9th International Conference and Exhibition on Pharmaceutical Development and Technology
Geneva, Switzerland
May 24-25, 2027
21st International Conference on Pharmaceutical Formulations & Drug Delivery
Tokyo, Japan
May 26-27, 2027
20th International Conference and Exhibition on Pharmacovigilance & Drug Safety
Rome, Italy
June 24-25, 2027
33rd International Conference on Advanced Clinical Research and Clinical Trials
Madrid, Spain
Global Market & Pharmaceutical Formulation Conference Speakers
Recommended Sessions
- Analytical strategies for pharmaceutical products
- Business Opportunities in Drug Delivery
- challenges in pharmaceutical research and development
- Global Market & Pharmaceutical Formulation
- Importance of Audit in Pharmaceutical Industry
- Major challenges in Drug Delivery
- Nano Pharmaceutics and Advanced Drug Delivery
- Nanotechnology in Drug Delivery
- Pharmaceutical Research and Development
- regulatory challenges in pharmaceutical industry
- Use of Nanoparticles in DDS and Newer Methodologies
Related Journals
Are you interested in
- Pharmaceutical Chemistry and Medicinal Chemistry - PHARMA CONFERENCE 2026 (Spain)
- 3D Printing in Pharmaceutical Formulations - Drug Devilvery 2027 (France)
- Active Pharmaceutical Ingredients - MedTech-2026 (Switzerland)
- Acupuncture - Naturalproducts 2026 (UAE)
- Advanced Biostatistics, Modeling & Simulation in Clinical Trials - EURO CLINICAL TRIALS 2026 (UK)
- Advanced Drug Delivery Systems - Drug Devilvery 2027 (France)
- Advanced Drug Delivery Systems - PHARMA EDUCATION 2027 (Italy)
- Advanced Drug Delivery Systems & Technologies - Drug Delivery 2027 (Austria)
- Advanced Drug Delivery Systems and Novel Formulation Strategies - Drug Safety 2027 (Italy)
- Advanced Pharmaceutical Analytical Technologies - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Advanced Pharmaceutical Research - PHARMA CONFERENCE 2026 (Spain)
- Advanced Pharmacokinetics - Pharmaceuticals-2027 (France)
- Advancements in Drug Delivery Systems - Pharmaceutica-2026 (Netherlands)
- Advances in Clinical Trial Design & Methodologies - EURO CLINICAL TRIALS 2026 (UK)
- Advances in Controlled Release Formulations - Pharmaceutica-2026 (Netherlands)
- Advances in Ocular Drug Delivery - Pharmaceutica-2026 (Netherlands)
- Advances in Pharmaceutical Analysis and Analytical Techniques - Drug Safety 2027 (Italy)
- Alternative Medicine and Complementary Medicine - Naturalproducts 2026 (UAE)
- Analytical strategies for pharmaceutical products - MedTech-2026 (Switzerland)
- Antimicrobial Drug Discovery and Development - Antibiotics Resistance 2027 (Spain)
- Antimicrobial Stewardship and Rational Antibiotic Use - Antibiotics Resistance 2027 (Spain)
- Antiplatelet and Anticoagulant Pharmacology - Cardiovascular-2027 (France)
- Arrhythmias and Antiarrhythmic Drug Therapy - Cardiovascular-2027 (France)
- Artificial Intelligence (AI) - Personalizedmedicine-2026 (Switzerland)
- Artificial Intelligence and Digital Tools for Rare Disease Diagnosis - ORPHAN DRUGS 2026 (France)
- Artificial Intelligence and Digital Transformation in Pharmaceutics - Drug Safety 2027 (Italy)
- Artificial Intelligence and Machine Learning in AMR Research - Antibiotics Resistance 2027 (Spain)
- Artificial Intelligence and Machine Learning in Drug Delivery - Drug Devilvery 2027 (France)
- Artificial Intelligence and Machine Learning in Drug Delivery Optimization - Pharmaceutica-2026 (Netherlands)
- Artificial Intelligence in Pharma - Pharmaceuticals-2027 (France)
- Artificial Intelligence in Pharmaceutical Sciences - PHARMA CONFERENCE 2026 (Spain)
- Artificial Intelligence in Pharmacy - PHARMA EDUCATION 2027 (Italy)
- Artificial Intelligence, Digital Transformation, and Data Science in Pharmaceutical Chemistry - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Artificial Intelligence, Machine Learning & Digital Drug Delivery - Drug Delivery 2027 (Austria)
- Artificial Intelligence, Machine Learning & Digital Innovations in Clinical Research - EURO CLINICAL TRIALS 2026 (UK)
- Atrial Fibrillation and Stroke Prevention - Cardiovascular-2027 (France)
- BCS and IVIVC Based Biowaivers - Eurobiosimilars 2027 (Italy)
- Bio-Pharmaceutical Sciences - Pharmaceuticals-2027 (France)
- Bioequivalence and Bioavailability - MedTech-2026 (Switzerland)
- Biological Medicine - Eurobiosimilars 2027 (Italy)
- Biologics and Biosimilars - Pharmaceutica-2026 (Netherlands)
- Biologics, Gene, and RNA Therapeutics - Drug Devilvery 2027 (France)
- Biologics, Peptides, Proteins & Vaccine Delivery - Drug Delivery 2027 (Austria)
- Biomarkers - Personalizedmedicine-2026 (Switzerland)
- Biopharmaceutical Informatics - Eurobiosimilars 2027 (Italy)
- Biopharmaceuticals & Advanced Therapeutics - PHARMA EDUCATION 2027 (Italy)
- Biopharmaceuticals and Biosimilars - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Biopharmaceuticals and Protein Delivery - Drug Devilvery 2027 (France)
- Biopharmaceutics and Drug Disposition - Pharmaceutica-2026 (Netherlands)
- Biopharmaceutics and Pharmacokinetics - PHARMA CONFERENCE 2026 (Spain)
- Biopharmaceutics and Pharmacokinetics in Drug Development - Drug Safety 2027 (Italy)
- Biosimilars and Generic Drug Development - Drug Safety 2027 (Italy)
- Biosimilars Approval to Biogenerics in Clinical Practice - Eurobiosimilars 2027 (Italy)
- Biosimilars Development in Markets - Eurobiosimilars 2027 (Italy)
- Biosimilars Market and Cost Analysis - Eurobiosimilars 2027 (Italy)
- Biosimilars Research Pipeline - Eurobiosimilars 2027 (Italy)
- Blockchain & Data Security in Clinical Research - EURO CLINICAL TRIALS 2026 (UK)
- Brain & CNS Drug Delivery - Drug Delivery 2027 (Austria)
- Cancer Pharmacology - Euro Pharmacology 2027 (France)
- Cardio-Oncology Pharmacology - Cardiovascular-2027 (France)
- Cardiovascular Drug Discovery and Development - Cardiovascular-2027 (France)
- Cardiovascular Drug Safety and Pharmacovigilance - Cardiovascular-2027 (France)
- Cardiovascular Pharmacology - Euro Pharmacology 2027 (France)
- Cardiovascular Pharmacology and Therapeutics - Cardiovascular-2027 (France)
- Cardiovascular Pharmacology in Women’s Health - Cardiovascular-2027 (France)
- Challenges and Future Innovations of Traditional Medicine - Naturalproducts 2026 (UAE)
- Challenges in Biosimilars Pharmacovigilance - Eurobiosimilars 2027 (Italy)
- Challenges In Pharmaceutical Formulations - Pharmatech 2027 (Switzerland)
- Chemical and Analytical Strategies for Biosimilars - Eurobiosimilars 2027 (Italy)
- Clinical Data Management, Biostatistics & AI Applications - EURO CLINICAL TRIALS 2026 (UK)
- Clinical Microbiology and Infectious Disease Management - Antibiotics Resistance 2027 (Spain)
- Clinical Pharmacology - Pharmaceuticals-2027 (France)
- Clinical Pharmacology and Drug Interactions - Drug Safety 2027 (Italy)
- Clinical Pharmacology and Therapeutics - Euro Pharmacology 2027 (France)
- Clinical Pharmacy & Patient-Centered Care - PHARMA EDUCATION 2027 (Italy)
- Clinical Pharmacy and Patient Care - PHARMA CONFERENCE 2026 (Spain)
- Clinical Pharmacy and Pharmacy Practices - MedTech-2026 (Switzerland)
- Clinical Research and Translational Pharmaceutical Chemistry - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Clinical Toxicology and Poison Management - Euro Pharmacology 2027 (France)
- Clinical Trials - Personalizedmedicine-2026 (Switzerland)
- Clinical Trials and Evidence-Based Research - PHARMA CONFERENCE 2026 (Spain)
- Clinical trials and Pharmacovigilance - MedTech-2026 (Switzerland)
- Clinical Trials and Real-World Evidence in Cardiovascular Pharmacology - Cardiovascular-2027 (France)
- Clinical Trials and Regulatory Affairs in Drug Development - Drug Safety 2027 (Italy)
- Clinical Trials in Medical Devices - EURO CLINICAL TRIALS 2026 (UK)
- Combination Drug Delivery Systems - Drug Devilvery 2027 (France)
- Computational Chemistry and Artificial Intelligence - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Computational Pharmacology and Artificial Intelligence - Euro Pharmacology 2027 (France)
- Consequences of Brexit on Biosimilars - Eurobiosimilars 2027 (Italy)
- Controlled and Sustained Release Formulations - Drug Devilvery 2027 (France)
- Coronary Artery Disease and Anti-Ischemic Drugs - Cardiovascular-2027 (France)
- COVID-19 & Emerging Infectious Diseases Clinical Research - EURO CLINICAL TRIALS 2026 (UK)
- CRISPR-Cas9 and Gene Editing Delivery - Drug Devilvery 2027 (France)
- Crude Drugs and Plant Products - Naturalproducts 2026 (UAE)
- Current Agency Expectations for Approval for Biosimilars - Eurobiosimilars 2027 (Italy)
- Current Challenges in Developing Biosimilars - Eurobiosimilars 2027 (Italy)
- Data Analytics - Personalizedmedicine-2026 (Switzerland)
- Diabetes, Metabolic Disorders and Cardiovascular Pharmacology - Cardiovascular-2027 (France)
- Digital Health - Personalizedmedicine-2026 (Switzerland)
- Digital Health, AI and Cardiovascular Pharmacology - Cardiovascular-2027 (France)
- Digital Health, Telemedicine & Remote Monitoring in Clinical Trials - EURO CLINICAL TRIALS 2026 (UK)
- Digital Pharma - Pharmatech 2027 (Switzerland)
- Digital Pharmacy & Smart Healthcare - PHARMA EDUCATION 2027 (Italy)
- Disease Prevention - Personalizedmedicine-2026 (Switzerland)
- Drug Delivery and Development - Eurobiosimilars 2027 (Italy)
- Drug Delivery and Gene Therapy - Pharmaceutica-2026 (Netherlands)
- Drug Delivery Challenges in Special Populations - Drug Safety 2027 (Italy)
- Drug Delivery for Cancer & Immunotherapy - Drug Delivery 2027 (Austria)
- Drug Delivery for Cardiovascular Diseases - Pharmaceutica-2026 (Netherlands)
- Drug Delivery in Cancer Therapy - Pharmaceutica-2026 (Netherlands)
- Drug Delivery in Infectious Diseases - Pharmaceutica-2026 (Netherlands)
- Drug Development & Translational Research - EURO CLINICAL TRIALS 2026 (UK)
- Drug Discovery - Pharmaceuticals-2027 (France)
- Drug Discovery & Development - PHARMA EDUCATION 2027 (Italy)
- Drug Discovery and Development - Pharmatech 2027 (Switzerland)
- Drug Discovery and Development - Euro Pharmacology 2027 (France)
- Drug Discovery and Medicinal Chemistry - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Drug discovery and NCEs - MedTech-2026 (Switzerland)
- Drug formulation - Pharmaceuticals-2027 (France)
- Drug Interactions and Polypharmacy in Cardiovascular Care - Cardiovascular-2027 (France)
- Drug Market access - Pharmaceuticals-2027 (France)
- Drug Metabolism - Pharmaceuticals-2027 (France)
- Drug Product Manufacturing - Pharmatech 2027 (Switzerland)
- Drug Regulatory Compliance - Pharmaceuticals-2027 (France)
- Drug Safety, Pharmacovigilance, and Risk Management - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Drug screening - Pharmaceuticals-2027 (France)
- Drug Stability Studies and Shelf Life Determination - Drug Safety 2027 (Italy)
- Drug Targeting and Design - Pharmaceutica-2026 (Netherlands)
- Drug Targeting and Design - Pharmatech 2027 (Switzerland)
- Electronic Health Records (EHRs) - Personalizedmedicine-2026 (Switzerland)
- Emerging Biosimilars in Therapeutics - Eurobiosimilars 2027 (Italy)
- Emerging Cardiovascular Therapies and Future Pharmacological Strategies - Cardiovascular-2027 (France)
- Emerging Drug Delivery Routes and Non-Invasive Technologies - Drug Safety 2027 (Italy)
- Emerging Technologies and Smart Drug Delivery - Drug Devilvery 2027 (France)
- Emerging Trends and Future Directions in Pharmaceutical Chemistry - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Emerging Trends in Personalized Medicine and Targeted Therapy - Drug Safety 2027 (Italy)
- Emerging Trends in Pharmaceutical Sciences - PHARMA CONFERENCE 2026 (Spain)
- Emerging Trends in Pharmacology - Euro Pharmacology 2027 (France)
- Endocrine Pharmacology - Euro Pharmacology 2027 (France)
- Environmental and Agricultural Impact on AMR Spread - Antibiotics Resistance 2027 (Spain)
- Environmental Toxicology - Euro Pharmacology 2027 (France)
- Ethical, Legal, and Social Issues (ELSI) in Rare Disease Research - ORPHAN DRUGS 2026 (France)
- Ethics, IRB & Patient Safety in Clinical Trials - EURO CLINICAL TRIALS 2026 (UK)
- Ethics, Sustainability, and Social Responsibility in Pharmaceutical Chemistry - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Exosome-Based Drug Delivery - Drug Devilvery 2027 (France)
- Experimental Pharmacology - Euro Pharmacology 2027 (France)
- Forensic Toxicology - Euro Pharmacology 2027 (France)
- Formulation Strategies for Follow-on Biologics - Eurobiosimilars 2027 (Italy)
- Formulations and NNDS - MedTech-2026 (Switzerland)
- Future Directions, Personalized Delivery & Translational Drug Delivery - Drug Delivery 2027 (Austria)
- Future Innovations & Emerging Trends in Clinical Research - EURO CLINICAL TRIALS 2026 (UK)
- Future Outlook and Innovations in Next-Generation Therapeutics - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Future Perspectives in Pharmaceutics and Drug Safety - Drug Safety 2027 (Italy)
- Future Trends in Pharmacy Practice - PHARMA EDUCATION 2027 (Italy)
- Gene & Cell Therapy Clinical Trials - EURO CLINICAL TRIALS 2026 (UK)
- Gene and RNA-Based Cardiovascular Therapies - Cardiovascular-2027 (France)
- Gene Editing and CRISPR Delivery - Drug Devilvery 2027 (France)
- Gene Therapy and CRISPR Technologies in Rare Disease Treatment - ORPHAN DRUGS 2026 (France)
- Gene, RNA & Nucleic Acid Delivery - Drug Delivery 2027 (Austria)
- Genetic Testing - Personalizedmedicine-2026 (Switzerland)
- Genomics - Personalizedmedicine-2026 (Switzerland)
- Genomics & Next-Generation Sequencing in Rare Diseases - ORPHAN DRUGS 2026 (France)
- Genomics, Bioinformatics and AMR Surveillance - Antibiotics Resistance 2027 (Spain)
- Geriatric Cardiovascular Pharmacology - Cardiovascular-2027 (France)
- Global Challenges and Future Perspectives in Pharmacology and Toxicology - Euro Pharmacology 2027 (France)
- Global Collaboration, Future Trends & Innovations in Clinical Research - EURO CLINICAL TRIALS 2026 (UK)
- Global Epidemiology and Disease Burden in Rare Conditions - ORPHAN DRUGS 2026 (France)
- Global Trends in Antimicrobial Resistance (AMR) - Antibiotics Resistance 2027 (Spain)
- Globalization of Biosimilars - Eurobiosimilars 2027 (Italy)
- Green and Sustainable Pharmaceutical Chemistry - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Health Equity - Personalizedmedicine-2026 (Switzerland)
- Heart Failure Pharmacology - Cardiovascular-2027 (France)
- Herbal Medicine - Naturalproducts 2026 (UAE)
- Herbal Medicine and Natural Products Research - PHARMA CONFERENCE 2026 (Spain)
- Homeopathic and Ayurvedic Medicines - Naturalproducts 2026 (UAE)
- Hospital and Community Pharmacy Practice - PHARMA CONFERENCE 2026 (Spain)
- Hospital-Acquired and Healthcare-Associated Infections (HAIs) - Antibiotics Resistance 2027 (Spain)
- Hydrogel-Based Drug Delivery - Drug Devilvery 2027 (France)
- Hypertension and Antihypertensive Therapy - Cardiovascular-2027 (France)
- Imaging-Guided Drug Delivery - Drug Devilvery 2027 (France)
- Immunopharmacology - Euro Pharmacology 2027 (France)
- Immunotherapy and Targeted Cancer Therapies - Drug Devilvery 2027 (France)
- Industrial Pharmacy and Manufacturing Technologies - PHARMA CONFERENCE 2026 (Spain)
- Infection Prevention and Control (IPC) Strategies - Antibiotics Resistance 2027 (Spain)
- Injectable and Parenteral Drug Delivery - Drug Devilvery 2027 (France)
- Injectable, Implantable & Controlled-Release Systems - Drug Delivery 2027 (Austria)
- Innovations In Pharmaceutical Technology - Pharmatech 2027 (Switzerland)
- Innovative Clinical Approach in Biosimilars - Eurobiosimilars 2027 (Italy)
- Innovative Therapeutics & Novel Drug Delivery Systems - EURO CLINICAL TRIALS 2026 (UK)
- Intellectual Property Rights - Eurobiosimilars 2027 (Italy)
- Intellectual Property, Patents, and Technology Transfer - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Legal Issues and BPCI Act - Eurobiosimilars 2027 (Italy)
- Lifestyle Medicine - Personalizedmedicine-2026 (Switzerland)
- Lipid Management and Cardiovascular Prevention - Cardiovascular-2027 (France)
- Lipid Nanoparticles, Liposomes & Lipid-Based Delivery - Drug Delivery 2027 (Austria)
- Marine Natural Products - Naturalproducts 2026 (UAE)
- Mechanisms of Antimicrobial Resistance in Pathogens - Antibiotics Resistance 2027 (Spain)
- Medical Pharmacology - Pharmaceuticals-2027 (France)
- Medicinal Chemistry - Naturalproducts 2026 (UAE)
- Medicinal Plant Research - Naturalproducts 2026 (UAE)
- Medicinal Plants as Anti-Cancer Drugs - Naturalproducts 2026 (UAE)
- Microbiome-Based Drug Delivery - Drug Devilvery 2027 (France)
- Microfluidics and Lab-on-a-Chip Systems in Drug Formulation - Drug Devilvery 2027 (France)
- Molecular and Cellular Pharmacology - Euro Pharmacology 2027 (France)
- Molecular Diagnostics in Infectious Diseases - Antibiotics Resistance 2027 (Spain)
- Monoclonal Antibody Biosimilars - Eurobiosimilars 2027 (Italy)
- mRNA and Nucleic Acid Therapeutics - Drug Devilvery 2027 (France)
- Nano medicine and Nanotechnology in Drug Delivery - Pharmaceutica-2026 (Netherlands)
- Nanomedicine & Nanoparticle-Based Drug Delivery - Drug Delivery 2027 (Austria)
- Nanomedicine and Advanced Drug Delivery - Cardiovascular-2027 (France)
- Nanomedicine and Nanotechnology in Drug Delivery - Drug Devilvery 2027 (France)
- Nanopharmacology and Drug Delivery - Euro Pharmacology 2027 (France)
- Nanotechnology & Nanomedicine - PHARMA EDUCATION 2027 (Italy)
- Nanotechnology and Nanomedicine - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Nanotechnology in Drug Delivery - PHARMA CONFERENCE 2026 (Spain)
- Nanotechnology in Drug Delivery and Therapeutics - Drug Safety 2027 (Italy)
- Natural Products - Naturalproducts 2026 (UAE)
- Natural Products and Herbal Drug Chemistry - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Natural Products and Herbal Pharmacology - Euro Pharmacology 2027 (France)
- Natural Products Chemistry - Naturalproducts 2026 (UAE)
- Neuropharmacology - Euro Pharmacology 2027 (France)
- New Sources and Approaches to Natural Products - Naturalproducts 2026 (UAE)
- Novel Antibiotics and Next-Generation Therapeutics - Antibiotics Resistance 2027 (Spain)
- Novel Drug Delivery Systems and Formulation Chemistry - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Novel Drug Delivery Systems, Biomarkers & Drug Targets - MedTech-2026 (Switzerland)
- Novel Drug Delivery Technologies - Pharmaceutica-2026 (Netherlands)
- Novel Drug Discovery and Development Approaches - Drug Safety 2027 (Italy)
- Nutraceuticals & Functional Medicine - Naturalproducts 2026 (UAE)
- Obesity Pharmacotherapy and Cardiovascular Risk - Cardiovascular-2027 (France)
- Occupational Health and Industrial Toxicology - Euro Pharmacology 2027 (France)
- One Health Approach to Antimicrobial Resistance - Antibiotics Resistance 2027 (Spain)
- Oral Drug Delivery Innovations - Drug Devilvery 2027 (France)
- Oral, Transdermal & Mucosal Drug Delivery - Drug Delivery 2027 (Austria)
- Orphan Drug Discovery and Development Strategies - ORPHAN DRUGS 2026 (France)
- Orphan Drugs and Rare Disease Drug Delivery - Drug Devilvery 2027 (France)
- Orphan Drugs and Rare Disease Therapeutics - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Patient Recruitment, Retention & Engagement Strategies - EURO CLINICAL TRIALS 2026 (UK)
- Patient-Cantered Care - Personalizedmedicine-2026 (Switzerland)
- Pediatric and Geriatric Pharmacology - Euro Pharmacology 2027 (France)
- Pediatric Cardiovascular Pharmacology - Cardiovascular-2027 (France)
- Pediatric, Geriatric, and Targeted Therapeutics - Drug Devilvery 2027 (France)
- Peptide and Protein Drug Delivery - Pharmaceutica-2026 (Netherlands)
- Personalized & Precision Medicine - PHARMA EDUCATION 2027 (Italy)
- Personalized and Precision Medicine - PHARMA CONFERENCE 2026 (Spain)
- Personalized Healthcare - Personalizedmedicine-2026 (Switzerland)
- Personalized Medicine and Precision Therapeutics - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Personalized Medicine, Precision Therapies & Real-World Evidence - EURO CLINICAL TRIALS 2026 (UK)
- Phage Therapy and Alternative Antimicrobial Strategies - Antibiotics Resistance 2027 (Spain)
- Pharma Analytical Techniques and Instrumentation - Pharmaceuticals-2027 (France)
- Pharma Market Research - MedTech-2026 (Switzerland)
- Pharmaceutical Analysis - Pharmatech 2027 (Switzerland)
- Pharmaceutical Analysis and Quality Assurance - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Pharmaceutical Analysis and Quality Control - PHARMA CONFERENCE 2026 (Spain)
- Pharmaceutical Biotechnology - Euro Pharmacology 2027 (France)
- Pharmaceutical Biotechnology and Biologics Development - Drug Safety 2027 (Italy)
- Pharmaceutical Biotechnology and Biopharmaceuticals - PHARMA CONFERENCE 2026 (Spain)
- Pharmaceutical Chemistry - Pharmatech 2027 (Switzerland)
- Pharmaceutical Drug Discovery and Development - PHARMA CONFERENCE 2026 (Spain)
- Pharmaceutical Education & Innovative Teaching - PHARMA EDUCATION 2027 (Italy)
- Pharmaceutical Industry - Pharmaceuticals-2027 (France)
- Pharmaceutical Industry - Pharmatech 2027 (Switzerland)
- Pharmaceutical Industry Trends - Pharmaceuticals-2027 (France)
- Pharmaceutical Innovation, Startups, and Industry - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Pharmaceutical Manufacturing and Pharmacoeconomics - MedTech-2026 (Switzerland)
- Pharmaceutical Manufacturing, Scale Up and Tech transfer - MedTech-2026 (Switzerland)
- Pharmaceutical Nano medicine and Targeted Therapy - PHARMA CONFERENCE 2026 (Spain)
- Pharmaceutical Nanotechnology - Pharmaceuticals-2027 (France)
- Pharmaceutical Packaging - Pharmaceuticals-2027 (France)
- Pharmaceutical Packaging - Pharmaceuticals-2027 (France)
- Pharmaceutical Packaging and Logistics - MedTech-2026 (Switzerland)
- Pharmaceutical Packaging, Stability, and Shelf-Life Studies - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Pharmaceutical Process Validation and Quality by Design (QbD) - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Pharmaceutical Regulatory Affairs - Pharmaceuticals-2027 (France)
- Pharmaceutical Regulatory Sciences and Global Compliance - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Pharmaceutical Research & Translational Medicine - PHARMA EDUCATION 2027 (Italy)
- Pharmaceutical Research and Development - Pharmatech 2027 (Switzerland)
- Pharmaceutical Sciences - MedTech-2026 (Switzerland)
- Pharmaceutical Sciences - Pharmaceuticals-2027 (France)
- Pharmaceutical Technology & Manufacturing - PHARMA EDUCATION 2027 (Italy)
- Pharmaceutics and Drug Delivery Systems - PHARMA CONFERENCE 2026 (Spain)
- Pharmaceutics and Pharmacotherapeutics - Pharmatech 2027 (Switzerland)
- Pharmacists Role in Patient Safety - Pharmatech 2027 (Switzerland)
- Pharmacoeconomics - MedTech-2026 (Switzerland)
- Pharmacoeconomics - Pharmaceuticals-2027 (France)
- Pharmacoeconomics - Pharmaceuticals-2027 (France)
- Pharmacogenetics - Personalizedmedicine-2026 (Switzerland)
- Pharmacogenomics - Personalizedmedicine-2026 (Switzerland)
- Pharmacogenomics and Pharmacoepidemiology - MedTech-2026 (Switzerland)
- Pharmacogenomics and Precision Cardiovascular Medicine - Cardiovascular-2027 (France)
- Pharmacogenomics and Precision Medicine - Euro Pharmacology 2027 (France)
- Pharmacokinetics and Drug Absorption Optimization - Drug Devilvery 2027 (France)
- Pharmacokinetics and Pharmacodynamics - Pharmaceutica-2026 (Netherlands)
- Pharmacokinetics and Pharmacodynamics - Euro Pharmacology 2027 (France)
- Pharmacokinetics, Pharmacodynamics & Bioavailability - Drug Delivery 2027 (Austria)
- Pharmacology - Pharmatech 2027 (Switzerland)
- Pharmacology & Therapeutic Innovations - PHARMA EDUCATION 2027 (Italy)
- Pharmacology and Toxicology - MedTech-2026 (Switzerland)
- Pharmacology and Toxicology Research - PHARMA CONFERENCE 2026 (Spain)
- Pharmacology, Toxicology, and ADMET Studies - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Pharmacovigilance & Drug Safety in Clinical Trials - EURO CLINICAL TRIALS 2026 (UK)
- Pharmacovigilance & Medication Safety - PHARMA EDUCATION 2027 (Italy)
- Pharmacovigilance and drug safety - Pharmaceuticals-2027 (France)
- Pharmacovigilance and Drug Safety - Euro Pharmacology 2027 (France)
- Pharmacovigilance and Drug Safety Monitoring - Drug Safety 2027 (Italy)
- Pharmacy Practice - Pharmaceuticals-2027 (France)
- Phytochemistry - Naturalproducts 2026 (UAE)
- Population Health - Personalizedmedicine-2026 (Switzerland)
- Precision Medicine - Personalizedmedicine-2026 (Switzerland)
- Process Chemistry and Pharmaceutical Manufacturing - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Public Health and Pharmaceutical Policy - PHARMA CONFERENCE 2026 (Spain)
- Pulmonary Hypertension and Targeted Therapies - Cardiovascular-2027 (France)
- QC & QA: Quality control and Quality assurance - MedTech-2026 (Switzerland)
- Quality Assurance and Quality Control in Pharmaceutical Industries - Drug Safety 2027 (Italy)
- Quality by design (QbD) approach - MedTech-2026 (Switzerland)
- Quality Control and Regulatory Considerations in Drug Delivery Systems - Pharmaceutica-2026 (Netherlands)
- Radiopharmaceuticals - Pharmaceuticals-2027 (France)
- Rare Autoimmune and Inflammatory Diseases - ORPHAN DRUGS 2026 (France)
- Rare Neurological and Neurodevelopmental Disorders - ORPHAN DRUGS 2026 (France)
- Rare Pediatric Diseases and Neonatal Screening Advances - ORPHAN DRUGS 2026 (France)
- Real-World Evidence, Decentralized Trials & Emerging Technologies - EURO CLINICAL TRIALS 2026 (UK)
- Regenerative Medicine & Stem Cell Clinical Trials - EURO CLINICAL TRIALS 2026 (UK)
- Regenerative Medicine and Cardiovascular Therapeutics - Cardiovascular-2027 (France)
- Regulatory Affairs & Global Compliance in Clinical Trials - EURO CLINICAL TRIALS 2026 (UK)
- Regulatory Affairs & Pharmaceutical Policy - PHARMA EDUCATION 2027 (Italy)
- Regulatory Affairs and Drug Approval Systems - PHARMA CONFERENCE 2026 (Spain)
- Regulatory Affairs and Quality Assurance in Pharmaceutics - Pharmaceutica-2026 (Netherlands)
- Regulatory Affairs, Quality Compliance, and Intellectual Property - PHARMACEUTICAL CHEMISTRY 2027 (Italy)
- Regulatory Authority Compliance - MedTech-2026 (Switzerland)
- Regulatory Guidelines and Global Compliance in Pharmaceuticals - Drug Safety 2027 (Italy)
- Regulatory Pharmacology and Toxicology - Euro Pharmacology 2027 (France)
- Regulatory Science, Manufacturing & Scale-Up of Drug Delivery Systems - Drug Delivery 2027 (Austria)
- Regulatory updates on Biosimilars - Eurobiosimilars 2027 (Italy)
- Regulatory, Quality Control, and Translational Aspects - Drug Devilvery 2027 (France)
- Reproductive and Developmental Toxicology - Euro Pharmacology 2027 (France)
- Risk Assessment and Safety Evaluation in Drug Development - Drug Safety 2027 (Italy)
- Smart Drug Delivery Systems - Pharmatech 2027 (Switzerland)
- Smart Polymers for Drug Delivery - Pharmaceutica-2026 (Netherlands)
- Smart, Stimuli-Responsive & Intelligent Drug Delivery - Drug Delivery 2027 (Austria)
- Stem Cell Therapy and Regenerative Medicine Applications - ORPHAN DRUGS 2026 (France)
- Supply Chain Management - Pharmaceuticals-2027 (France)
- Supply Chain Management - Pharmaceuticals-2027 (France)
- Targeted & Precision Drug Delivery - Drug Delivery 2027 (Austria)
- Targeted Oral and Gastro-Resistant Formulations - Drug Devilvery 2027 (France)
- Targeted Therapies - Personalizedmedicine-2026 (Switzerland)
- Technology in Pharma Sciences - MedTech-2026 (Switzerland)
- Telemedicine - Personalizedmedicine-2026 (Switzerland)
- Theranostics and Personalized Medicine - Drug Devilvery 2027 (France)
- Toxicology and Risk Assessment - Euro Pharmacology 2027 (France)
- Track 10: Clinical Trial Safety - Clinical Trials-2027 (UK)
- Track 10: Proteomics - Pharma Expo-2027 (France)
- Track 11: Clinical Trial Operations - Clinical Trials-2027 (UK)
- Track 11: Pharmacokinetics - Pharma Expo-2027 (France)
- Track 12. Pharmacogenomics - Pharma Expo-2027 (France)
- Track 12: Decentralized Clinical Trials - Clinical Trials-2027 (UK)
- Track 13: Microbiology - Pharma Expo-2027 (France)
- Track 13: Pharmacovigilance Quality Management - Clinical Trials-2027 (UK)
- Track 14: Metabolomics - Pharma Expo-2027 (France)
- Track 14: Safety Communication - Clinical Trials-2027 (UK)
- Track 15: Chemotherapy - Pharma Expo-2027 (France)
- Track 15: Emerging Therapies Safety - Clinical Trials-2027 (UK)
- Track 1: Bioprocessing - Pharma Expo-2027 (France)
- Track 1: Medical Device Safety - Clinical Trials-2027 (UK)
- Track 2: Immunotherapy - Pharma Expo-2027 (France)
- Track 2: Medication Errors - Clinical Trials-2027 (UK)
- Track 3: Benefit-Risk Assessment - Clinical Trials-2027 (UK)
- Track 3: Nanotechnology - Pharma Expo-2027 (France)
- Track 4: Pharmacogenomics - Pharma Expo-2027 (France)
- Track 4: Post-Marketing Safety - Clinical Trials-2027 (UK)
- Track 5: Adverse Event Reporting - Clinical Trials-2027 (UK)
- Track 5: Toxicology - Pharma Expo-2027 (France)
- Track 6: Nutraceuticals - Pharma Expo-2027 (France)
- Track 6: Pharmacovigilance Databases - Clinical Trials-2027 (UK)
- Track 7: Bioethics - Pharma Expo-2027 (France)
- Track 7: Pharmacoepidemiology - Clinical Trials-2027 (UK)
- Track 8: Drug Utilization Research - Clinical Trials-2027 (UK)
- Track 8: Pharmacovigilance - Pharma Expo-2027 (France)
- Track 9: Bioinformatics - Pharma Expo-2027 (France)
- Track 9: Patient-Reported Outcomes - Clinical Trials-2027 (UK)
- Transdermal and Topical Drug Delivery - Drug Devilvery 2027 (France)
- Translational Research - Personalizedmedicine-2026 (Switzerland)
- USFDA Approved Biosimilars - Eurobiosimilars 2027 (Italy)
- Vaccine Delivery Systems - Pharmaceutica-2026 (Netherlands)
- Vaccine Development and Immunopharmacology - Drug Safety 2027 (Italy)
- Vaccines as a Strategy to Combat AMR - Antibiotics Resistance 2027 (Spain)
- Vascular Pharmacology and Endothelial Function - Cardiovascular-2027 (France)
- Wearable and Implantable Drug Delivery Devices - Drug Devilvery 2027 (France)